Creegan & Nassoura Financial Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$1.51M |
| 2 |
Honeywell
HON
|
+$1.08M |
| 3 |
Blackstone
BX
|
+$992K |
| 4 |
Broadcom
AVGO
|
+$903K |
| 5 |
Nike
NKE
|
+$557K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$187K |
| 2 |
Unilever
UL
|
+$124K |
| 3 |
Stryker
SYK
|
+$105K |
| 4 |
Verizon
VZ
|
+$102K |
| 5 |
Palantir
PLTR
|
+$95K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.98% |
| 2 | Industrials | 17.37% |
| 3 | Financials | 16.17% |
| 4 | Consumer Staples | 12.8% |
| 5 | Technology | 8.05% |
Similar funds
Creegan & Nassoura Financial Group's Q3 2022 Portfolio in Review
As of Q3 2022, Creegan & Nassoura Financial Group held 77 positions worth $115M, down 3% from $119M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Creegan & Nassoura Financial Group deployed $5.11M of net new capital in Q3 2022, opening 4 new positions and adding to 16 existing holdings. Its largest new stake was Medtronic: 16,849 shares worth $1.36M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was US Bancorp, an estimated $187K trimmed.
- Creegan & Nassoura Financial Group's largest Q3 2022 buy was Medtronic: 16,849 shares worth $1.36M.
- Creegan & Nassoura Financial Group added most to Blackstone in Q3 2022, an estimated $992K increase.
- Creegan & Nassoura Financial Group's biggest Q3 2022 reduction was US Bancorp, cutting an estimated $187K.
- Creegan & Nassoura Financial Group fully exited Palantir in Q3 2022, selling an estimated $95K.
- Creegan & Nassoura Financial Group's ten largest holdings make up 31% of its $115M portfolio in Q3 2022.
- Creegan & Nassoura Financial Group opened 4 new positions and closed 1 in Q3 2022.
- Creegan & Nassoura Financial Group's portfolio value fell 3% quarter-over-quarter to $115M.
Based on Creegan & Nassoura Financial Group's 13F filing for Q3 2022, filed 14 Nov 2022.